Literature DB >> 24882199

Quantity and quality of psychotherapy trials for depression in the past five decades.

Peiyao Chen1, Toshiaki A Furukawa2, Kiyomi Shinohara1, Mina Honyashiki1, Hissei Imai1, Kayoko Ichikawa1, Deborah M Caldwell3, Vivien Hunot4, Rachel Churchill4.   

Abstract

BACKGROUND: Over the years randomized controlled trials (RCTs) of various psychotherapies for treating depression have provided evidence to demonstrate the interventions' efficacy/effectiveness. However, recent researches suggest that the quality of some RCTs were actually less than ideal, which could hence have biased their results. The present study aims to assess (1) the changes in characteristics of RCTs of psychotherapies for treating adult depression; (2) the temporal changes in their trial quality, and (3) the quality differences among different therapeutic approaches.
METHODS: We included 135 RCTs of psychotherapies treating adult depression published from year 1969 to 2011. Temporal changes in trials' characteristics including their quantity and quality were assessed at study-level and arm-level. Quality differences among different schools of psychotherapy were assessed at arm-level.
RESULTS: Changes in quantity and improvements in methodological quality were found at study-level. Positive changes in trial quality at arm-level were observed in most aspects. Comparisons made across different schools of psychotherapy revealed statistically significant differences among them, with earlier behavior therapy trials doing worst and more recent third wave cognitive-behavior therapy doing best. LIMITATIONS: We could not determine whether the observed changes in quality resulted from actual improvement in trial quality and/or from improved reporting. The relatively smaller number of arms for several types of interventions could weaken the representativeness when making comparisons across psychotherapeutic approaches.
CONCLUSION: Our study revealed positive temporal changes in both trial quantity and quality over the past five decades and has also spotted possible areas for further improvement.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depressive disorder; Psychotherapies; Randomized controlled trials

Mesh:

Year:  2014        PMID: 24882199     DOI: 10.1016/j.jad.2014.04.071

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  4 in total

1.  How to prove that your therapy is effective, even when it is not: a guideline.

Authors:  P Cuijpers; I A Cristea
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-28       Impact factor: 6.892

2.  A guideline for whom?

Authors:  T A Furukawa
Journal:  Epidemiol Psychiatr Sci       Date:  2015-10-29       Impact factor: 6.892

Review 3.  Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials.

Authors:  Toshi A Furukawa; Erica S Weitz; Shiro Tanaka; Steven D Hollon; Stefan G Hofmann; Gerhard Andersson; Jos Twisk; Robert J DeRubeis; Sona Dimidjian; Ulrich Hegerl; Roland Mergl; Robin B Jarrett; Jeffrey R Vittengl; Norio Watanabe; Pim Cuijpers
Journal:  Br J Psychiatry       Date:  2017-01-19       Impact factor: 9.319

4.  Behavioral activation for late adolescents with subthreshold depression: a randomized controlled trial.

Authors:  Koki Takagaki; Yasumasa Okamoto; Ran Jinnin; Asako Mori; Yoshiko Nishiyama; Takanao Yamamura; Satoshi Yokoyama; Syouichi Shiota; Yuri Okamoto; Yoshie Miyake; Akiko Ogata; Yoshihiko Kunisato; Haruki Shimoda; Norito Kawakami; Toshi A Furukawa; Shigeto Yamawaki
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-03-22       Impact factor: 4.785

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.